Alhowail, A. H. (2025). Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA. Frontiers in Pharmacology, 16, 1592511.

Alotayk, L. I., Aldubayan, M. A., Alenezi, S. K., Anwar, M. J., & Alhowail, A. H. (2023). Comparative evaluation of chemotherapeutics on cognitive dysfunction. Biomedicine and Pharmacotherapy, 165, 115245.

Alsaud, M. M., Alhowail, A. H., Aldubayan, M. A., & Almami, I. S. (2023). The ameliorative effect of pioglitazone against neuroinflammation caused by doxorubicin in rats. Molecules, 28(12), 4775.

Altunkaya, M., Ateş, M. B., Bulut, A., Abuşoğlu, G., & Öztürk, B. (2025). Cisplatin-induced toxicity in the hippocampus: Dose-dependent damage. BMC Pharmacology and Toxicology, 26(1), 215.

Barbosa-Azevedo, M., Dias-Carvalho, A., Carvalho, F., & Costa, V. M. (2024). Chemotherapy-induced cognitive impairment and glia. Toxicology and Applied Pharmacology, 492, 117085.

Carozzi, V. A., Chiorazzi, A., Canta, A., Oggioni, N., Gilardini, A., Rodriguez-Menendez, V., & Cavaletti, G. (2009). Effect of chronic combined administration of cisplatin and paclitaxel in a rat model of neurotoxicity. European Journal of Cancer, 45(4), 656–665.

Christie, L. A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012). Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clinical Cancer Research, 18(7), 1954–1965.

Csik, B., Vali Kordestan, K., Gulej, R., Patai, R., Nyul-Toth, A., Shanmugarama, S., & Csiszar, A. (2025). Cisplatin and methotrexate induce brain microvascular endothelial and microglial senescence in mouse models of chemotherapy-associated cognitive impairment. GeroScience, 47, 3447–3459.

Dietrich, J., Prust, M., & Kaiser, J. (2015). Chemotherapy, cognitive impairment and hippocampal toxicity. Neuroscience, 309, 224–232.

Domouky, A. M., Deraz, R. H., & Abdel-Kareem, R. H. (2022). Neurotoxicity of cisplatin in the rat hippocampus: histological and biochemical study. Egyptian Society of Clinical Toxicology Journal, 10(1), 29–48.

Groves, T. R., Farris, R., Anderson, J. E., Alexander, T. C., Kiffer, F., Carter, G., & Allen, A. R. (2017). Chemotherapy with 5-fluorouracil upregulates cytokine expression and alters hippocampal dendritic complexity in aged mice. Behavioural Brain Research, 316, 215–224.

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., & Landreth, G. E. (2005). Acute treatment with the PPARγ agonist pioglitazone reduces glial inflammation. Brain, 128(6), 1442–1453.

Hussien, M., & Yousef, M. I. (2022). Neuroprotective effects against cisplatin-induced neurotoxicity. Environmental Science and Pollution Research International, 29(41), 62042–62654.

Kang, S., Lee, S., Kim, J., Kim, J. C., Kim, S. H., Son, Y., Shin, T., Youn, B. H., Kim, J. S., Wang, H., & Yang, M. (2018). Chronic chemotherapy affects hippocampal micromorphometry. Experimental Neurobiology, 27(5), 419–436.

Kirchev, V. V., Jctapenko, I. O., Tertyshnyi, S. V., Buryachkivskyi, S. E., & Vastyanov, R. S. (2025). Neuroprotective effects of deproteinized calf blood haemodialysate in case of intranasally administration under chronic cerebral ischemia. Odessa Medical Journal, 192, 14–19.

Kumar, A., Kaundal, R. K., Iyer, S., & Sharma, S. S. (2009). Effects of pioglitazone on cognitive dysfunction and oxidative stress. Behavioural Brain Research, 197(2), 472–479.

Lomelí-Cardona, N., Chávez-Munguía, B., García-Rodríguez, A., & Bota, D. A. (2017). Cisplatin-induced mitochondrial dysfunction and oxidative stress in the brain. Free Radical Biology and Medicine, 108, 41–50.

Magdy, O., Eshra, M., Rashed, L., Maher, M., Hosny, S. A., & Shams Eldeen, A. M. (2024). Amelioration of cisplatin-induced neurodegenerative changes in rats and restoration of mitochondrial biogenesis by 6-bromoindirubin-3′-oxime: The implication of the GSK-3β/PGC1-α axis. Tissue and Cell, 88, 102393.

Manohar, S., Jamesdaniel, S., & Salvi, R. (2014). Cisplatin inhibits hippocampal cell proliferation and alters hippocampal neurogenesis. Neurotoxicology Research, 25(4), 369–380.

Morales-Garcia, J. A., Luna-Medina, R., Alfaro-Cervello, C., Cortes-Canteli, M., Santos, A., Garcia‐Verdugo, J. M., & Perez-Castillo, A. (2011). PPARγ activation promotes neural stem cell proliferation. Glia, 59(2), 293–307.

Nair, A. B., & Jacob, S. (2016). A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy, 7(2), 27–31.

Oliveros, A., Yoo, K. H., Rashid, M. A., Corujo-Ramirez, A., Hur, B., Sung, J., & Jang, M. H. (2022). Adenosine A2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function. Proceedings of the National Academy of Sciences of the United States of America, 119(28), e2206415119.

Ongnok, B., Chattipakorn, N., & Chattipakorn, S. C. (2020). Doxorubicin and cisplatin induced cognitive impairment: possible mechanisms and interventions. Experimental Neurology, 324, 113118.

Qutifan, S., Saleh, T., Shahin, N. A., ELBeltagy, M., Obeidat, F., Qattan, D., & Alsalem, M. (2024). Melatonin mitigates cisplatin-induced cognitive impairment in rats and improves hippocampal dendritic spine density. Neuroreport, 35(10), 657–663.

Reagan-Shaw, S., Nihal, M., & Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB Journal, 22(3), 659–661.

Ren, X., St Clair, D. K., & Butterfield, D. A. (2017). Dysregulation of cytokine-mediated chemotherapy-induced cognitive impairment. Pharmacological Research, 117, 267–273.

Squillace, S., Niehoff, M. L., Doyle, T. M., Green, M., Esposito, E., Cuzzocrea, S., Christopher, K. Arnatt, Spiegel, S., Farr, S. A., & Salvemini, D. (2022). S1PR1 activation drives cisplatin-induced cognitive impairment. Journal of Clinical Investigation, 132(17), e157738.

Umfress, A., Speed, H. E., Tan, C., Ramezani, S., Birnbaum, S., Brekken, R. A., Sun, Х, & Plattner, F (2021). Neuropathological effects of chemotherapeutic drugs. ACS Chemical Neuroscience, 12, 3038–3048.

Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y., Lu, Z., & Abalo, R. (2022). Mechanisms of chemotherapy-induced neurotoxicity. Frontiers in Pharmacology, 13, 750507.

Wellenberg, A., Brinkmann, V., Bornhorst, J., Ventura, N., Honnen, S., & Fritz, G. (2021). Cisplatin-induced neurotoxicity and serotonergic disruption. Pharmacological Research, 174, 105921.

Xing, B., Xin, T., Hunter, R. L., & Bing, G. (2007). Pioglitazone inhibition of microglial activation reduces neuronal loss. Journal of Neuroimmunology, 189(1–2), 38–46.